Advisory Research Inc. grew its stake in shares of TriMas Co. (NASDAQ:TRS - Free Report) by 41.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 754,089 shares of the industrial products company's stock after purchasing an additional 220,000 shares during the period. TriMas makes up 3.1% of Advisory Research Inc.'s investment portfolio, making the stock its 5th largest holding. Advisory Research Inc. owned approximately 1.86% of TriMas worth $18,543,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also recently made changes to their positions in the company. Sterling Capital Management LLC increased its holdings in shares of TriMas by 815.5% during the 4th quarter. Sterling Capital Management LLC now owns 1,300 shares of the industrial products company's stock valued at $32,000 after purchasing an additional 1,158 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new position in TriMas in the 4th quarter worth approximately $202,000. Quantbot Technologies LP boosted its holdings in shares of TriMas by 203.5% during the 4th quarter. Quantbot Technologies LP now owns 11,978 shares of the industrial products company's stock worth $295,000 after purchasing an additional 8,031 shares during the last quarter. Wells Fargo & Company MN lifted its position in TriMas by 21.1% during the fourth quarter. Wells Fargo & Company MN now owns 37,729 shares of the industrial products company's stock worth $928,000 after buying an additional 6,573 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in TriMas by 3.3% during the third quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company's stock worth $982,000 after buying an additional 1,227 shares during the last quarter. Institutional investors own 99.42% of the company's stock.
TriMas Trading Up 1.3 %
Shares of NASDAQ:TRS traded up $0.26 during mid-day trading on Tuesday, reaching $20.50. 93,591 shares of the company were exchanged, compared to its average volume of 304,613. TriMas Co. has a 1 year low of $19.33 and a 1 year high of $28.51. The firm's 50-day simple moving average is $22.61 and its 200 day simple moving average is $24.50. The firm has a market cap of $834.68 million, a price-to-earnings ratio of 32.01 and a beta of 0.55. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44.
TriMas Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 13th. Shareholders of record on Tuesday, May 6th will be paid a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.78%. TriMas's dividend payout ratio (DPR) is presently 27.12%.
Insider Activity at TriMas
In other TriMas news, Director Shawn Sedaghat bought 554,149 shares of the company's stock in a transaction that occurred on Monday, March 10th. The shares were purchased at an average price of $24.07 per share, with a total value of $13,338,366.43. Following the completion of the acquisition, the director now directly owns 900,974 shares of the company's stock, valued at $21,686,444.18. This represents a 159.78 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Scott A. Mell sold 2,218 shares of the stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $22.54, for a total value of $49,993.72. Following the completion of the transaction, the chief financial officer now owns 26,288 shares in the company, valued at approximately $592,531.52. The trade was a 7.78 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders acquired 806,246 shares of company stock worth $19,338,213. Corporate insiders own 14.20% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, BWS Financial reissued a "buy" rating and issued a $40.00 price objective on shares of TriMas in a report on Friday, February 28th.
Check Out Our Latest Stock Analysis on TRS
TriMas Profile
(
Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Stories

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.